propranolol has been researched along with Corneal Neovascularization in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with corneal neovascularization complicating the Stevens-Johnson syndrome, not responsive to steroids and cyclosporine, were treated with propranolol eye drops." | 7.88 | Propranolol eye drops in patients with corneal neovascularization. ( de Libero, C; Filippi, L; Fortunato, P; Piozzi, E; Zamma Gallarati, B, 2018) |
| "To evaluate the inhibitory effects of propranolol, a nonselective and lipophilic β-adrenergic receptor blocker, on alkali-induced corneal neovascularization (NV)." | 7.80 | The effect of β receptor blockade through propranolol on corneal neovascularization. ( Bucak, YY; Erdurmus, M; Kükner, AŞ; Önder, Hİ; Simavli, H; Terzi, EH, 2014) |
| "Two patients with corneal neovascularization complicating the Stevens-Johnson syndrome, not responsive to steroids and cyclosporine, were treated with propranolol eye drops." | 3.88 | Propranolol eye drops in patients with corneal neovascularization. ( de Libero, C; Filippi, L; Fortunato, P; Piozzi, E; Zamma Gallarati, B, 2018) |
| "To evaluate the inhibitory effects of propranolol, a nonselective and lipophilic β-adrenergic receptor blocker, on alkali-induced corneal neovascularization (NV)." | 3.80 | The effect of β receptor blockade through propranolol on corneal neovascularization. ( Bucak, YY; Erdurmus, M; Kükner, AŞ; Önder, Hİ; Simavli, H; Terzi, EH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filippi, L | 1 |
| de Libero, C | 1 |
| Zamma Gallarati, B | 1 |
| Fortunato, P | 1 |
| Piozzi, E | 1 |
| Simavli, H | 1 |
| Erdurmus, M | 1 |
| Terzi, EH | 1 |
| Bucak, YY | 1 |
| Önder, Hİ | 1 |
| Kükner, AŞ | 1 |
2 other studies available for propranolol and Corneal Neovascularization
| Article | Year |
|---|---|
Propranolol eye drops in patients with corneal neovascularization.
Topics: Child; Child, Preschool; Corneal Neovascularization; Female; Humans; Male; Ophthalmic Solutions; Pro | 2018 |
The effect of β receptor blockade through propranolol on corneal neovascularization.
Topics: Adrenergic beta-Antagonists; Animals; Burns, Chemical; Caspase 3; Caustics; Corneal Neovascularizati | 2014 |